Bartlett & Co Wealth Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bartlett & Co Wealth Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,863	Closed	-$90.3K	–	1205
2022 Q3	$90.3K	Hold	2,863	–	–	﹤0.01%	470
2022 Q2	$87.1K	Sell	2,863 -1,826	-39%	-$49.4K	﹤0.01%	483
2022 Q1	$122K	Buy	+4,689	New	+$112K	﹤0.01%	453
2021 Q4	–	Sell	-4,689	Closed	-$90.2K	–	937
2021 Q3	$90.2K	Sell	4,689 -150	-3%	-$2.99K	﹤0.01%	427
2021 Q2	$107K	Hold	4,839	–	–	﹤0.01%	400
2021 Q1	$127K	Sell	4,839 -300	-6%	-$7.13K	﹤0.01%	382
2020 Q4	$96K	Hold	5,139	–	–	﹤0.01%	419
2020 Q3	$87.3K	Buy	5,139 +300	+6%	+$5.83K	﹤0.01%	402
2020 Q2	$113K	Hold	4,839	–	–	﹤0.01%	368
2020 Q1	$40.6K	Hold	4,839	–	–	﹤0.01%	501
2019 Q4	$47.3K	Hold	4,839	–	–	﹤0.01%	547
2019 Q3	$45.9K	Hold	4,839	–	–	﹤0.01%	545
2019 Q2	$57.5K	Hold	4,839	–	–	﹤0.01%	415
2019 Q1	$85.2K	Hold	4,839	–	–	﹤0.01%	339
2018 Q4	$84K	Hold	4,839	–	–	﹤0.01%	327
2018 Q3	$72.1K	Hold	4,839	–	–	﹤0.01%	378
2018 Q2	$76.9K	Hold	4,839	–	–	﹤0.01%	361
2018 Q1	$68.7K	Buy	+4,839	New	+$71.6K	﹤0.01%	389

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bartlett & Co Wealth Management's VIVO Position: Q4 2022 in Review

Bartlett & Co Wealth Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 2,863 shares — an estimated $90.3K sold.

Bartlett & Co Wealth Management first reported a position in VIVO in Q1 2018 and held it in 18 quarters. The position peaked at $127K in Q1 2021. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

Bartlett & Co Wealth Management reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
Bartlett & Co Wealth Management sold 2,863 Meridian Bioscience Inc shares in Q4 2022, an estimated $90.3K.
Bartlett & Co Wealth Management first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 18 quarters.
Bartlett & Co Wealth Management's Meridian Bioscience Inc position peaked at $127K in Q1 2021.
218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Bartlett & Co Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2024.